Oncology
Israel Lowy from Regeneron interview with Nicole Raleigh

ESMO 2024 - Israel (Izzy) Lowy

ESMO 2024, which followed hot on the heels of this year’s World Conference on Lung Cancer, was abuzz with data around PD-1 inhibitors, LAG-3 inhibitors, and the possibilities for using exis

Oncology
Sven Schaffer and Nicole Raleigh interview at ESMO

ESMO 2024 - Sven Schaffer

The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in Barcelona.

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. UK and US agree zero tariffs on pharma – with price rises
  2. FDA clears trial of 'vectorised' ALS antibody from VectorY
  3. Tracy Beth Hoeg will be fifth CDER head this year
  4. FDA takes steps to limit non-human primate testing
  5. FDA could hike user fees for ex-US drug programmes

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more